The idea that US interest rates will stay higher for longer is probably wrong 
Adobe Unveils Acrobat AI Assistant Tool for Acrobat and Reader Users 
PepsiCo Issues Recall for Schweppes Ginger Ale Over Sugar Content 
Why Africa can be the beating heart of South Korea’s technology industry 
Nike Innovates for Mothers with New Apparel and Footwear 
Industry shutdowns are messy and painful: 4 lessons Australia’s coal sector can learn from car-makers about bowing out 
Burger King Launches New Whopper in South Korea After Chaotic Marketing Campaign 
The Nike Luka 3, Unveiled with Advanced Technology and Sustainability 
Introduction of Green License Plates in S, Korea Pull Down Sales of Porsche, Rolls Royce, Bentley 
Pay Blockchain Fees with Klever KDA Tokens 
BMW Korea's Investment in S. Korean Suppliers of ₩6.63 Trillion Surpasses its Annual Revenue in the Country 
PUMA and Scuderia Ferrari Launch a New Era of Summer Fashion with Crews Go Summer Collection 
HMM Announces Major Fleet Expansion to Boost Global Competitiveness 
GSK Consumer Healthcare Korea was revealed to have appointed a new chief executive officer, and it was revealed to be Shin Dong Woo, a former CEO of the company’s branch in Hong Kong.
According to The Korea Times, GSK Consumer Healthcare Korea announced the assignment of CEO Shin earlier this week. It was reported that the new chief has been with the company for 28 years and has led GSK in various international businesses - from consumer health care to general consumer goods.
He also led other health care firms such as Pfizer and Sanofi. Prior to his assignment as the new chief at GSK Consumer Healthcare Korea, he has been leading the Honk Kong unit for the last two years. During his tenure, he has many achievements, including boosting the business and building the foundation for its stability.
At Sanofi Korea, he became the first president of the He also completed the company's integration with Pfizer Consumer Healthcare, where he was CEO of the Korean branch and the Asia-Pacific region between 2015 and 2020.
Shin also became the very first president of the French multinational healthcare company’s Korean unit. He helped established the brand in the country and introduced major products that are now selling very well here., and this is not all. Shin has extensive experience in marketing as well as he worked at Coca-Cola, L’Oreal, and Fox Home Entertainment and was in charge of marketing and sales for more than a decade.
Meanwhile, Shin will lead GSK Consumer Healthcare Korea, which has recently changed its name to Haleon. This will be the company’s official name as it starts its consumer healthcare venture. The name means the company will also change all of its product packaging.
"With the announcement of 'Haleon' today, we are one step closer to our goal of becoming a consumer healthcare company,” Haleon’s CEO-nominee, Brian McNamara, said in a press release in February. “'Haleon' will stand as a leader in the consumer healthcare industry with the vision of delivering better daily health to mankind.”
“Haleon” is the outcome of the successful merging of Novartis in 2015 and Pfizer's consumer healthcare portfolio in 2019 over the past eight years.
